Literature DB >> 6458432

Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies.

S Berrih, C Gaud, M A Bach, H Le Brigand, J P Binet, J F Bach.   

Abstract

Functional T cell subsets have been evaluated in the peripheral blood of patients with myasthenia gravis using monoclonal anti-T cell antibodies and a suppressor cell assay based on the suppression of the mixed-lymphocyte reaction by concanavalin A-activated lymphocytes. A significant decline of suppressor cells was found in a large proportion of patients, both by direct count using the anti-suppressor-cytotoxic T cell antibody (OKT8) and by the suppressor assay. Patients also showed an increase in immature T cells defined by their simultaneous reaction with the anti-helper cell (OKT4) and anti-suppressor cell (OKT8) antibody. Thymectomy tended to enhance the deficit in suppressor cells, and to induce the disappearance of double-labelled cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6458432      PMCID: PMC1537262     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  HL-A antigens in myasthenia gravis.

Authors:  D Fritze; C Herrman; F Naeim; G S Smith; R L Walford
Journal:  Lancet       Date:  1974-02-16       Impact factor: 79.321

Review 2.  Evaluation of T-cells and thymic serum factors in man using the rosette technique.

Authors:  J F Bach
Journal:  Transplant Rev       Date:  1973

3.  The thymus in myasthenia gravis. Evidence for altered cell populations.

Authors:  N I Abdou; R P Lisak; B Zweiman; I Abrahamsohn; A S Penn
Journal:  N Engl J Med       Date:  1974-12-12       Impact factor: 91.245

4.  Enhanced immune responsiveness to a thymus-independent antigen early after adult thymectomy: evidence for short-lived inhibitory thymus-derived cells.

Authors:  R S Kerbel; D Eidinger
Journal:  Eur J Immunol       Date:  1972-04       Impact factor: 5.532

5.  The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells.

Authors:  U Galili; M Schlesinger
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

6.  [100 thymectomies in myasthenic patients. Remote results].

Authors:  H Le Brigand; P Leuasseur; M Merlier; A Rojas-Miranda; C Gaud; Y Noviant
Journal:  Rev Neurol (Paris)       Date:  1972-04       Impact factor: 2.607

7.  HL-A haplotypes of 32 diseases.

Authors:  P I Terasaki; M R Mickey
Journal:  Transplant Rev       Date:  1975

Review 8.  The differentiation and function of human T lymphocytes.

Authors:  E L Reinherz; S F Schlossman
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

9.  Progesterone deficiency and premature labour.

Authors:  A I Csapo; O Pohanka; H L Kaihola
Journal:  Br Med J       Date:  1974-01-26

10.  Studies in myasthenia gravis: effects of thymectomy. Results on 185 patients with nonthymomatous and thymomatous myasthenia gravis, 1941-1969.

Authors:  A E Papatestas; L I Alpert; K E Osserman; R S Osserman; A E Kark
Journal:  Am J Med       Date:  1971-04       Impact factor: 4.965

View more
  39 in total

1.  Phenotypic analysis of peripheral CD4+ CD8+ T cells in the rat.

Authors:  E Kenny; D Mason; A Pombo; F Ramírez
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

2.  Lymphocyte subpopulations in patients with alcoholic liver disease.

Authors:  R Jovanovic; T Worner; C S Lieber; F Paronetto
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

3.  Circulating CD4+CD8+ T lymphocytes in patients with Kawasaki disease.

Authors:  J Hirao; K Sugita
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

4.  Circulating CD4+CD8+ cells in myasthenia gravis: supplementary immunological parameter for long-term prognosis.

Authors:  M Matsui; H Fukuyama; I Akiguchi; M Kameyama
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

Review 5.  Immunopathogenesis and treatment of myasthenia gravis.

Authors:  A I Levinson; B Zweiman; R P Lisak
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

6.  Increased circulating Ia-positive T cells in patients with idiopathic thrombocytopenic purpura.

Authors:  H Mizutani; T Tsubakio; Y Tomiyama; S Katagiri; T Tamaki; Y Kurata; T Yonezawa; S Tarui
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

7.  Impairment of T lymphocyte functions in mice with motor end-plate disease.

Authors:  M Papiernik; F Rieger; S Ezine; M Pincon-Raymond
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

8.  Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).

Authors:  R M Talaat; A M Elmaghraby; S S Barakat; M El-Shahat
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

9.  Circulating CD3+ CD4+ CD8+ T lymphocytes in multiple sclerosis.

Authors:  F E Munschauer; C Stewart; L Jacobs; S Kaba; Z Ghorishi; S J Greenberg; D Cookfair
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

10.  Defense mechanism and macroscopic tumor growth in lung tissue.

Authors:  K Kayser; W Ebert; N M Merkle; H D Becker
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.